Repligen (RGEN) Other Operating Expenses (2010 - 2026)

Repligen (RGEN) posted quarterly Other Operating Expenses of $103000.0 for Q2 2026, up 100.75% quarter-over-quarter from -$13.8 million in Q1 2026.

Repligen (RGEN) Other Operating Expenses (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Other Operating Expenses for 17 consecutive years, with $103000.0 the latest figure, recorded in Q2 2026.

In Q2 2026, Other Operating Expenses changed N/A year-over-year to $103000.0; the TTM figure through Jun 2026 stood at $163.0 million (down 22.09% YoY), while the FY2025 annual figure was $338.4 million, down 6.77% from the prior year.
Other Operating Expenses rose to $103000.0 in Q2 2026 per RGEN's latest filing, from -$13.8 million in the prior quarter.
Across five years, Other Operating Expenses topped out at $131.9 million in Q4 2024 and bottomed at -$13.8 million in Q1 2026.
Historically, Other Operating Expenses has averaged $72.9 million across 5 years, with a median of $79.7 million in 2022.
Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 48.48% — and 2025, when it declined 29.82%.
Repligen's Other Operating Expenses stood at $73.6 million in 2022, then grew by 20.74% to $88.8 million in 2023, then jumped by 48.48% to $131.9 million in 2024, then dropped by 29.82% to $92.6 million in 2025, then slumped by 99.89% to $103000.0 in 2026.
Business Quant data shows RGEN's Other Operating Expenses at $103000.0 in Q2 2026, -$13.8 million in Q1 2026, and $92.6 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Repligen	10.25 Bn	9.24 Bn	110.04 Mn

Download Data